Novel sphingolipid heterocyclic compounds as modulators of sphingolipid signaling and uses thereof

摘要

The present invention relates to new sphingolipid heterocyclic compounds as modulators of sphingolipid signaling and uses thereof as pharmaceutically active agents, suitable for treating proliferative, degenerative, infectious, and other diseases.
wherein X is selected from a methylene group (CH 2 ) and oxygen (O);
and pharmaceutically acceptable salts thereof.